welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
Earlier start of corticosteroids in DMD linked to earlier heart disease onset, study suggests
Researchers say it is important to carefully assess the timing of the start of corticosteroid treatment for Duchenne muscular dystrophy (DMD) in children and its potential association with disease outcomes.
The study, “Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy,” was published in the journal Neuromuscular Disorders.
DMD is an inherited childhood-onset disease characterized by mutations in the DMD gene that provides instructions for making a protein called dystrophin, located primarily in skeletal muscles used for movement and in the heart muscle. These mutations lead to progressive muscle weakness.
rareRelated
-
Bone health in boys with Duchenne Muscular Dystrophy on long-term daily deflazacort therapyQuality of life in Duchenne Muscular Dys...
-
Effect of Deflazacort and Prednisone versus Placebo on Muscle Strength in Boys with Duchenne Muscular Dystrophy Who ...Objective: To assess the effects of def...
-
Corticosteroids for Duchenne Muscular DystrophyNeurologists from the American Academy o...
-
ICER Releases Draft Evidence Report on Treatments for Duchenne Muscular DystrophyThe Institute for Clinical and Economic ...
-
The evaluation of bone age in patients with Duchenne muscular dystrophy on long-term glucocorticoid treatmentLong-term treatment with glucocorticoids...
-
Longitudinal Pulmonary Function Testing Outcome Measures in Duchenne Muscular Dystrophy: Long-term Natural History w...We describe changes in pulmonary functio...
-
Spironolactone Versus Prednisolone in DMDThis is a randomized, open-label, pilot ...